Chemical Structure (Combogesic 01)
Combogesic Tablet, Film Coated
Product Images NDC 0143-9432
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Combogesic (NDC 0143-9432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Combogesic 02)
Figure 1 (Combogesic 03)
This text seems to be a comparison of pain intensity differences (in mm) between different medications over time. It includes the medications ComboGesic, Ibuprofen, Acetaminophen, and Placebo, with corresponding sample sizes for each group. The table likely displays how these medications alleviate pain intensity at specific time points.*
Principal Display Panel (325 mg/97.5 mg Tablet Bottle Label)
This text describes a medication called Combogesic, which is a combination of acetaminophen and ibuprofen. Each film-coated tablet contains 325 mg of acetaminophen and 97.5 mg of ibuprofen. It is recommended to keep the medication out of reach of children and store it at temperatures between 20°C-25°C (68°F-77°F), with excursions permitted to 15°C-30°C (59°F-86°F). The medication guide is required to be provided to each patient separately. The medication is manufactured by Catalent Greenvill Inc. in North Carolina, USA, and distributed by Hikma Pharmaceuticals USA Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
